Opportunity
SAM #75N98026Q00979
Procurement of Illumina NextSeq 2000 Sequencing System and Service Contract for NCI
Buyer
NIH Office of Logistics and Acquisition Operations
Posted
August 14, 2026
Respond By
August 24, 2026
Identifier
75N98026Q00979
NAICS
811219, 334516
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), is seeking to procure a NextSeq 2000 desktop sequencing system and a related service contract. - Government Buyer: - National Institutes of Health (NIH) - National Cancer Institute (NCI) - OEM Highlight: - Illumina, Inc. is the specified Original Equipment Manufacturer (OEM) - Products and Services Requested: - 1 Illumina NextSeq 2000 desktop sequencing system - 1 Illumina service contract for maintenance and repairs - Notable Requirements: - The sequencing system must be compatible with existing Illumina sequencing libraries and analytical pipelines to ensure data continuity for cancer research - Maintenance and repairs must be performed by Illumina-authorized personnel to maintain warranty coverage - The procurement is intended to support ongoing genetic analysis and research continuity at NCI
Description
See attached NOI - Notice of Intent